These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23558962)

  • 1. microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report.
    Kowalewska M; Bakula-Zalewska E; Chechlinska M; Goryca K; Nasierowska-Guttmejer A; Danska-Bidzinska A; Bidzinski M
    Tumour Biol; 2013 Aug; 34(4):2153-60. PubMed ID: 23558962
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    de Almeida BC; Dos Anjos LG; Uno M; Cunha IWD; Soares FA; Baiocchi G; Baracat EC; Carvalho KC
    Cells; 2019 Nov; 8(11):. PubMed ID: 31744257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
    Rommel B; Holzmann C; Bullerdiek J
    Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.
    de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
    Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
    Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
    PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and subclinical endometritis induced alterations in bovine endometrial transcriptome and miRNome profile.
    Salilew-Wondim D; Ibrahim S; Gebremedhn S; Tesfaye D; Heppelmann M; Bollwein H; Pfarrer C; Tholen E; Neuhoff C; Schellander K; Hoelker M
    BMC Genomics; 2016 Mar; 17():218. PubMed ID: 26965375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
    Gonzalez Dos Anjos L; de Almeida BC; Gomes de Almeida T; Mourão Lavorato Rocha A; De Nardo Maffazioli G; Soares FA; Werneck da Cunha I; Baracat EC; Carvalho KC
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30200635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures.
    Ravid Y; Formanski M; Smith Y; Reich R; Davidson B
    Gynecol Oncol; 2016 Mar; 140(3):512-7. PubMed ID: 26768834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer.
    Biamonte F; Santamaria G; Sacco A; Perrone FM; Di Cello A; Battaglia AM; Salatino A; Di Vito A; Aversa I; Venturella R; Zullo F; Costanzo F
    Sci Rep; 2019 Apr; 9(1):5668. PubMed ID: 30952937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of microRNA let-7a, miR-155, and miR-205 in tumor and tumor-adjacent histologically normal tissue in patients with non-small cell lung cancer].
    Shikeeva AA; Kekeeva TV; Zavalishina LE; Andreeva YY; Zaletaev DV; Frank GA
    Arkh Patol; 2016; 78(3):3-10. PubMed ID: 27296000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Uterine Mesenchymal Neoplasms.
    Kertowidjojo EC; Bennett JA
    Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionality of the Tumor Suppressor
    Stope MB; Cernat V; Kaul A; Diesing K; Koensgen D; Burchardt M; Mustea A
    Anticancer Res; 2018 Mar; 38(3):1547-1550. PubMed ID: 29491084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POTENTIAL DIAGNOSTIC BIOMARKERS FOR HUMAN MESENCHYMAL TUMORS, ESPECIALLY LMP2/Β1I AND CYCLIN E1/MIB1 DIFFERENTIAL EXPRESSION: PRUM-IBIO STUDY.
    Tanabe Y; Hayashi T; Okada M; Aburatani H; Tonegawa S; Abiko K; Konishi I
    Georgian Med News; 2024 May; (350):42-48. PubMed ID: 39089269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
    Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
    Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNAs in oral cancer: Moving from bench to bed as next generation medicine.
    D'Souza W; Kumar A
    Oral Oncol; 2020 Dec; 111():104916. PubMed ID: 32711289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
    Busca A; Parra-Herran C
    Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.